Gastrointestinal stromal tumours: an update
Tóm tắt
Recently, there has been intense interest in the study of gastrointestinal stromal tumour (GIST); one might call it a virtual GIST revolution. This is due largely to the realization that most GISTs express KIT and harbour activating
Từ khóa
Tài liệu tham khảo
Golden T, 1941, Smooth muscle tumors of the gastrointestinal tract and retroperitoneal tissues, Surg. Gynecol. Obstet., 73, 784
Appelman HD., 1986, Smooth muscle tumors of the gastrointestinal tract. What we know now that Stout didn't know, Am. J. Surg. Pathol., 10, 83
Welsh RA, 1969, Ultrastructure of gastric leiomyoma, Arch. Pathol., 87, 71
Walker P, 1986, Gastrointestinal autonomic nerve (GAN) tumor. Ultrastructural evidence for a newly recognized entity, Arch. Pathol. Lab. Med., 110, 309
Herrera GA, 1989, Gastrointestinal autonomic nerve tumors. ‘Plexosarcomas’, Arch. Pathol. Lab. Med., 113, 846
Tsujimura T, 1991, Characterization of Ws mutant allele of rats: a 12‐base deletion in tyrosine kinase domain of c‐kit gene, Blood, 78, 1942, 10.1182/blood.V78.8.1942.1942
Ramon y Cajal S., 1893, Sur les ganglions et plexus nerveux de l'intestin, Comp. Rend. Soc. Biol. Paris, 45, 217
Kindblom LG, 2002, Incidence, prevalence, phenotype and biologic spectrum of gastrointestinal stromal cell tumors (GIST)—a population‐based study of 600 cases, Ann. Oncol., 13, 157
Tworek JA, 1997, Stromal tumors of the jejunum and ileum, Mod. Pathol., 10, 200
Demetri GD, 2004, NCCN task force report: optimal management of patients with gastrointestinal stromal tumor (GIST)—expansion and update of NCCN clinical practice guidelines, JNCCN, 2, S1
Suster S, 1996, Gastrointestinal stromal tumors with prominent signet‐ring cell features, Mod. Pathol., 9, 609
Kindblom LG, 1998, Gastrointestinal pacemaker cell tumor (GIPACT): gastrointestinal stromal tumors show phenotypic characteristics of the interstitial cells of Cajal, Am. J. Pathol., 152, 1259
Mikhael AI, 1994, CD34 expression in stromal tumors of the gastrointestinal tract, Appl. Immunohistochem., 2, 89
Sarlomo‐Rikala M, 1998, CD117: a sensitive marker for gastrointestinal stromal tumors that is more specific than CD34, Mod. Pathol., 11, 728
Allander SV, 2001, Gastrointestinal stromal tumors with KIT mutations exhibit a remarkably homogeneous gene expression profile, Cancer Res., 61, 8624
Hasegawa T, 1997, CD34 expression by inflammatory fibroid polyps of the stomach, Mod. Pathol., 10, 451
Rubin BP, 2001, KIT activation is a ubiquitous feature of gastrointestinal stromal tumors, Cancer Res., 61, 8118
Antonescu CR, 2003, Association of KIT exon 9 mutations with nongastric primary site and aggressive behavior: KIT mutation analysis and clinical correlates of 120 gastrointestinal stromal tumors, Clin. Cancer Res., 9, 3329
Hongyo T, 2000, Specific c‐kit mutations in sinonasal natural killer/T‐cell lymphoma in China and Japan, Cancer Res., 60, 2345
Sreekantaiah C, 1993, Chromosomal abnormalities in leiomyosarcomas, Am. J. Pathol., 142, 293
Bergmann F, 1998, Cytogenetic and morphologic characteristics of gastrointestinal stromal tumors. Recurrent rearrangement of chromosome 1 and losses of chromosomes 14 and 22 as common anomalies, Verh. Dtsch Ges. Pathol., 82, 275
El‐Rifai W, 1996, DNA copy number losses in chromosome 14: an early change in gastrointestinal stromal tumors, Cancer Res., 56, 3230
O'Leary T, 1999, Loss of heterozygosity at 1p36 predicts poor prognosis in gastrointestinal stromal/smooth muscle tumors, Lab. Invest., 79, 1461
El‐Rifai W, 2000, DNA sequence copy number changes in gastrointestinal stromal tumors: tumor progression and prognostic significance, Cancer Res., 60, 3899
Appelman H, 1977, Cellular leiomyomas of the stomach in 49 patients, Arch. Pathol. Lab. Med., 101, 373
Appelman HD., 1990, Mesenchymal tumors of the gut: historical perspectives, new approaches, new results and does it make any difference, Monogr. Pathol., 31, 220
Ernst SI, 1998, KIT mutation portends poor prognosis in gastrointestinal stromal/smooth muscle tumors, Lab. Invest., 78, 1633
Taniguchi M, 1999, Effect of c‐kit mutation on prognosis of gastrointestinal stromal tumors, Cancer Res., 59, 4297
Kawai J, 2005, Telomerase activity as prognostic factor in gastrointestinal stromal tumors of the stomach, Hepatogastroenterology, 52, 959
Gunther T, 2000, Telomerase activity and expression of hTRT and hTR in gastrointestinal stromal tumors in comparison with extragastrointestinal sarcomas, Clin. Cancer Res., 6, 1811
Demetri GD, 2005, Phase 3, multicenter, randomized, double‐blind, placebo‐controlled trial of SU11248 in patients (pts) following failure of imatinib for metastatic GIST, Proc. Am. Soc. Clin. Oncol., 23
Demetri GD, 2004, SU11248, a multi‐targeted tyrosine kinase inhibitor, can overcome imatinib (IM) resistance caused by diverse genomic mechanisms in patients (pts) with metastatic gastrointestinal stromal tumor (GIST), Proc. Am. Soc. Clin. Oncol., 22, 195
Maki RG, 2005, Results from a continuation trial of SU11248 in patients (pts) with imatinib (IM)‐resistant gastrointestinal stromal tumor (GIST), Proc. Am. Soc. Clin. Oncol., 24